Wird geladen...
Thrombin activation of PAR-1 contributes to microvascular stasis in mouse models of sickle cell disease
Vaso-occlusive crisis (VOC) is the primary cause of morbidity and hospitalization in sickle cell disease (SCD); however, only 4 therapies (hydroxyurea, l-glutamine, crizanlizumab, and voxeletor) are currently approved in SCD. These agents limit the duration, severity, and frequency of crises. Activa...
Gespeichert in:
Veröffentlicht in: | Blood |
---|---|
Hauptverfasser: | , , , , , , , , , |
Format: | Artigo |
Sprache: | Inglês |
Veröffentlicht: |
American Society of Hematology
2020
|
Schlagworte: | |
Online Zugang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7225686/ https://ncbi.nlm.nih.gov/pubmed/31977004 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1182/blood.2019003543 |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|